Financial Support for Mothers of Premature Infants
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Financial Transfers, Financial Assistance, Monetary Support for mothers of premature infants?
How does the treatment Financial Transfers differ from other treatments for mothers of premature infants?
Financial Transfers is unique because it provides direct monetary support to mothers of premature infants, which is not a standard medical treatment. This approach focuses on alleviating financial stress, potentially improving the overall well-being of the mother and infant, rather than addressing medical conditions directly.678910
What is the purpose of this trial?
Preterm birth is a leading cause of childhood mortality and developmental disabilities. Socioeconomic disparities in the incidence of preterm birth and morbidities, mortality, and quality of care for preterm infants persist. An important predictor of the long-term consequences of preterm birth is maternal presence during the prolonged infant hospitalization (weeks to months) in the neonatal intensive care unit (NICU). Mothers who visit the NICU can pump breast milk, directly breastfeed and engage in skin-to-skin care, which facilitates breast milk production and promotes infant physiologic stability and neurodevelopment. Low-income mothers face significant barriers to frequent NICU visits, including financial burdens and the psychological impact of financial stress, which hinder their participation in caregiving activities. The investigators will conduct an randomized controlled trial (RCT) to test the effectiveness of financial transfers among 420 Medicaid - eligible mothers with infants 24 - 34 weeks' gestation in four level 3 NICUs: Boston Medical Center (BMC) in Boston, Massachusetts, UMass Memorial Medical Center (UMass) in Worcester, Massachusetts, Baystate Medical Center in Springfield, Massachusetts, and Grady Memorial Hospital in Atlanta, Georgia. Mothers in the intervention arm will receive usual care enhanced with weekly financial transfers and will be informed that these transfers are meant to help them spend more time with their infant in the NICU vs. a control arm (usual care). The primary hypothesis is that financial transfers can enable economically disadvantaged mothers to visit the NICU, reduce the negative psychological impacts of financial distress, and increase maternal caregiving behaviors associated with positive preterm infant health and development.
Research Team
Margaret Parker, MD
Principal Investigator
UMass Memorial Health
Margaret McConnell, PhD
Principal Investigator
Harvard School of Public Health (HSPH)
Eligibility Criteria
This trial is for low-income mothers with Medicaid who have given birth to preterm infants (24-33 weeks' gestation) at specific hospitals in Massachusetts and Georgia. The study aims to help these mothers spend more time in the NICU with their babies by providing financial support.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Mothers in the intervention group receive weekly financial transfers to support NICU visits and caregiving activities
Follow-up
Participants are monitored for outcomes such as maternal caregiving behaviors and infant health post-discharge
Treatment Details
Interventions
- Financial Transfers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Harvard School of Public Health (HSPH)
Lead Sponsor
University of Massachusetts, Worcester
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator